The COG SDC consists of experienced Ph.D. level statisticians located at major universities directing the statistical analysis of COG data. In addition to this strong core of professionals, COG data are collected, managed and archived at one location: the COG Research Data Center at the University of Florida in Gainesville FL. This model combines the experience of professional statisticians, some of who have worked in pediatric oncology for more than 20 years, with a data management center with a long history of service to the pediatric research community. This model provides significant advantages to the research agenda of COG. The statistical leadership is comprised of individuals with significant experience in the design and analysis of clinical trials. Data are collected at a single site using uniform conventions and overseen by individuals with years of experience in this area. This makes data collection more efficient for institutional investigators and promotes the aggregation of large databases representing years of clinical trials work. The major goals of the SDC are: (1) participate in setting Group scientific priorities in specific disease areas through membership on strategy groups, tasks forces, and discipline committees; (2) evaluate COG therapeutic, epidemiologic, and biologic studies that are proposed or in development, to ensure the stated study aims can be accomplished (3) provide a study design, data acquisition plan and study analysis plan that ensures the study aims will be addressed correctly and efficiently, with appropriate monitoring of patient safety. (4) Perform statistical analyses of data relevant to interim monitoring and final reporting of the results of COG studies; (5) ensure that the needs of COG studies for data collection, computerization, report generation, committee review, safety monitoring, data quality control and institutional performance are met; (6) Investigate and test current information technology tools and adopt those that provide the most efficient means of quality data collection; (7) Establish policies for study conduct that ensure appropriate evaluation of study questions; (8) develop or extend statistical methodology to address unique problems arising in Group investigations; and (9) Provide training in the statistical aspects of the Group's scientific endeavors to various members of COG.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
1U10CA098413-01
Application #
6561230
Study Section
Subcommittee G - Education (NCI)
Program Officer
Smith, Malcolm M
Project Start
2003-06-20
Project End
2005-02-28
Budget Start
2003-06-20
Budget End
2004-02-29
Support Year
1
Fiscal Year
2003
Total Cost
$6,215,919
Indirect Cost
Name
National Childhood Cancer Foundation
Department
Type
DUNS #
624124301
City
Arcadia
State
CA
Country
United States
Zip Code
91006
Teot, Lisa A; Schneider, Michaela; Thorner, Aaron R et al. (2018) Clinical and mutational spectrum of highly differentiated, paired box 3:forkhead box protein o1 fusion-negative rhabdomyosarcoma: A report from the Children's Oncology Group. Cancer 124:1973-1981
Untanu, Ramona Vesna; Back, Jason; Appel, Burton et al. (2018) Variant histology, IgD and CD30 expression in low-risk pediatric nodular lymphocyte predominant Hodgkin lymphoma: A report from the Children's Oncology Group. Pediatr Blood Cancer 65:
Henderson, Tara O; Parsons, Susan K; Wroblewski, Kristen E et al. (2018) Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis. Cancer 124:136-144
de Alarcon, Pedro A; Matthay, Katherine K; London, Wendy B et al. (2018) Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial. Lancet Child Adolesc Health 2:25-34
Walterhouse, David O; Barkauskas, Donald A; Hall, David et al. (2018) Demographic and Treatment Variables Influencing Outcome for Localized Paratesticular Rhabdomyosarcoma: Results From a Pooled Analysis of North American and European Cooperative Groups. J Clin Oncol :JCO2018789388
Marks, Lianna J; McCarten, Kathleen M; Pei, Qinglin et al. (2018) Pericardial effusion in Hodgkin lymphoma: a report from the Children's Oncology Group AHOD0031 protocol. Blood 132:1208-1211
Stockard, Bradley; Garrett, Timothy; Guingab-Cagmat, Joy et al. (2018) Distinct Metabolic features differentiating FLT3-ITD AML from FLT3-WT childhood Acute Myeloid Leukemia. Sci Rep 8:5534
Aldrink, Jennifer H; Appel, Burton; Kaplan, Joel A et al. (2018) Surgeon Concordance in the Assessment of Resectability for Stage IA Nodular Lymphocyte Predominant Hodgkin Lymphoma. J Pediatr Hematol Oncol 40:246-247
Mullen, Elizabeth A; Chi, Yueh-Yun; Hibbitts, Emily et al. (2018) Impact of Surveillance Imaging Modality on Survival After Recurrence in Patients With Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group. J Clin Oncol :JCO1800076
Laetsch, Theodore W; Roy, Angshumoy; Xu, Lin et al. (2018) Undifferentiated Sarcomas in Children Harbor Clinically Relevant Oncogenic Fusions and Gene Copy-Number Alterations: A Report from the Children's Oncology Group. Clin Cancer Res 24:3888-3897

Showing the most recent 10 out of 473 publications